Home > Healthcare > Medical Devices > Diagnostic Devices > Microbiology Testing Market

Microbiology Testing Market Trends

Report ID: GMI5821
Published Date: May 2023
Report Format: PDF

Download Free Sample

Microbiology Testing Market Trends

Rising incidence of infectious diseases and outbreaks of epidemics have increased the demand for microbiology testing across the globe. The accurate and timely detection of pathogens, monitoring of resistance patterns, and implementation of appropriate control measures are vital for mitigating the impact of these diseases on public health. Outbreak of infectious diseases, such as COVID-19, influenza, and Ebola among others have increased the product adoption for early detection, diagnosis, and containment of the disease. Microbiology testing helps identify the causative pathogens, track their spread, and implement appropriate public health measures to control the outbreak. Microbiology testing plays a critical role in guiding appropriate antimicrobial therapy optimizing treatment outcomes and reducing the development of antimicrobial resistance.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for microbiology testing was worth around USD 4.9 billion in 2022 and is estimated to amass more than USD 11.9 billion by 2032 owing to the outbreak of pandemics, coupled with technological advancements in microbiology testing products.

Instruments accounted for more than 63% of the microbiology testing market revenue in 2022 and are set to record significant growth in adoption driven by several factors such as technological advancements, expanded testing volume, and rapid and accurate results, among others.

The U.S. market size is estimated to reach USD 4.4 billion by the end of 2032 owing to the presence of key market players and an increase in the occurrences of chronic diseases.

The microbiology testing industry consists of top companies such as Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation (Cepheid Inc.), F. Hoffmann-La Roche Ltd, Hologic Corporation, Merck KGaA, NEOGEN Corporation, QIAGEN, Shimadzu Corporation, and Thermo Fisher Scientific Inc., among others.